BioSpace News Archive

ADC Therapeutics SA, a commercial-stage biotechnology company improving the lives of those affected by cancer with its next-generation, targeted antibody drug conjugates for patients with hematologic malignancies and solid tumors, reported financial results for the second quarter ended June 30, 2021 and provided business updates.

Fact.MR – A Market Research and Competitive Intelligence Provider: Fact. MR in its latest report forecasts that the global sales of medical camera will witness a 1.4X increase during the forecast period, reaching a market valuation of around US$5 Bn by 2031 end.

The latest research findings from the team of Professor Yang Zifeng from the State Key Laboratory of Respiratory Disease in Guangzhou, China, have showed that Chinese medicine Lianhua Qingwen has an effective inhibitory action on the Delta variant of SARS-CoV-2.

In the first half of 2021, Boehringer Ingelheim has supplied more humans and animals worldwide with innovative medicines than ever before.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced that it will report its second quarter 2021 financial results and provide an update on the cytisinicline development program on Thursday, August 12, 2021 at 4:30PM EDT.

United Therapeutics Corporation announced that Martine Rothblatt, Ph.D., Chairperson and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company’s business during a fireside chat session at the 2021 Wedbush PacGrow Healthcare Virtual Conference.

Eli Lilly and Company and Incyte announced results from an additional cohort of 101 adult patients from the COV-BARRIER trial.

Tachyon Therapeutics, Inc. and AbCellera announced a collaboration to facilitate the discovery and development of a therapeutic antibody targeting LEFTY1, a member of the transforming growth factor β superfamily and validated extracellular drug target expressed in advanced cancers.

Karuna Therapeutics, Inc. announced that Steve Paul, M.D., chief executive officer, president and chairman will participate in a panel titled “The Brains of the Operation - Novel Approaches in Neuro” at the 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021 at 12:00 p.m. ET.

Sage Therapeutics, Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, reported business highlights and financial results for the second quarter ended June 30, 2021.